Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distributions of the HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 alleles and haplotype frequencies of 1763 stem cell donors in the Colombian Bone Marrow Registry typed by next-generation sequencing. | Front Immunol | 2022 | 36700199 | PubTator, text mining | PubMed |
| High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration. | Front Genet | 2022 | 36685833 | PubTator, text mining | PubMed |
| A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients. | Front Immunol | 2022 | 36685584 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| Immunogenetic Predisposition to SARS-CoV-2 Infection. | Biology (Basel) | 2022 | 36671730 | PubTator, text mining | PubMed |
| Identification of hub genes related to Duchenne muscular dystrophy by weighted gene co-expression network analysis. | Medicine (Baltimore) | 2022 | 36596079 | PubTator, text mining | PubMed |
| SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. | BMC Cancer | 2022 | 36585688 | PubTator, text mining | PubMed |
| Characteristic analysis of skin keratinocytes in patients with type 2 diabetes based on the single-cell levels. | Chin Med J (Engl) | 2022 | 36583863 | PubTator, text mining | PubMed |
| Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial. | BMC Med | 2022 | 36581917 | PubTator, text mining | PubMed |
| iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories. | Int J Mol Sci | 2022 | 36555728 | PubTator, text mining | PubMed |
| Identification of DDX60 as a Regulator of MHC-I Class Molecules in Colorectal Cancer. | Biomedicines | 2022 | 36551849 | PubTator, text mining | PubMed |
| Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma. | Front Immunol | 2022 | 36544782 | PubTator, text mining | PubMed |
| Single-cell transcriptomic, transcriptomic, and metabolomic characterization of human atherosclerosis. | Ann Transl Med | 2022 | 36544681 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies C1QA/B+ macrophages with multiple immune checkpoints associated with esophageal squamous cell carcinoma (ESCC) liver metastasis. | Ann Transl Med | 2022 | 36544679 | PubTator, text mining | PubMed |
| Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes. | Mol Neurodegener | 2022 | 36536457 | PubTator, text mining | PubMed |
| Potential biomarkers for active renal involvement in systemic lupus erythematosus patients. | Front Med (Lausanne) | 2022 | 36530895 | PubTator, text mining | PubMed |
| HSP70 and TNF Loci Polymorphism Associated with the Posner-Schlossman Syndrome in a Southern Chinese Population. | J Immunol Res | 2022 | 36530572 | PubTator, text mining | PubMed |
| Brain autopsies of critically ill COVID-19 patients demonstrate heterogeneous profile of acute vascular injury, inflammation and age-linked chronic brain diseases. | Acta Neuropathol Commun | 2022 | 36528671 | PubTator, text mining | PubMed |
| Proteomic profiling of end-stage COVID-19 lung biopsies. | Clin Proteomics | 2022 | 36526981 | PubTator, text mining | PubMed |
| Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology. | Sci Immunol | 2022 | 36525505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=30